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EDITORIAL

Diabetes and Coronary Artery Disease: Role of Functional Imaging
Maseeh uz Zaman and Nosheen Fatima

Diabetes mellitus (DM) is considered a global epidemic,
as according to the International Diabetic Federation
(IDF), in year 2015, about 415 million people were
diabetics with an expected involvement of 642 million
people in 2040.1 Most important concern is that more
than 50% of disease burden exists in the Southeast Asia
and Western-Pacific regions.1 More than 90% of these
diabetics have type-2 DM, which is non-insulin-dependent.
According to the National Cholesterol Education Program
(NCEP) guidelines, DM is considered equivalent to
coronary artery disease (CAD).2 CAD is the leading
cause of death in diabetics, being responsible for about
80% of the cardiovascular deaths (CVD). The overall
prevalence of the CAD in diabetics is about 55%; and
out of these, about 20% are asymptomatic.3 On the
contrary, the prevalence of CAD in non-diabetics is 2-4%.3
CAD in diabetics is more perplexed than non-diabetics
because of diffuse disease involving epicardial and
small vessels, generalized endothelial dysfunction, and
extensive disease at the time of the diagnosis.4
According to Framingham Study, diabetics have 4- 5-fold
increased risk of left ventricular dysfunction and
congestive heart failure.5 It is also a known fact that
diabetics tend to have less favorable outcome to
revascularization and their overall survival is 10 years
shorter than non-diabetics.5

Over the last two decades, there has been significant
decline in cardiovascular mortality in general population
due to the robust development in pharmacotherapy and
interventional techniques. Unfortunately, these figures
are not impressive in diabetics. According to FINMONICA
trial, mortality after the first myocardial infarction is
significantly higher in diabetics than non-diabetic
population.6 Furthermore, diabetic women tend to have
poor outcome than diabetic male after the hospitalization
for acute coronary syndrome (ACS).7 However, the
aggressive medical management, like use of statins, has
significantly declined the CV mortality in diabetics as
observed in a Scandinavian trial (Scandinavian
Simvastatin Survival Study; 4S Trial).8 Therefore, an
early diagnosis of CAD is considered as the key to
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success in diabetics. According to the American Diabetic
Association (ADA) guidelines, published in 2016.
Routine screening for CAD in asymptomatic diabetics is
not recommended because it does not improve
outcomes as long as atherosclerotic CV risk factors are
treated.9 However, it recommends investigation for CAD
in diabetics with typical or atypical cardiac symptoms
with or without ECG abnormalities. A large number of
investigative tools are available for the diagnosis of
CAD, ranging from the most commonly used noninvasive exercise tolerance test (ETT) to the invasive
coronary angiography as gold standard. Many
anatomical imaging modalities like echocardiography,
cardiac MR (cMR) and CT angiography (CTA) are
available for the diagnosis of CAD. Myocardial perfusion
imaging (MPI), being a nuclear cardiology tool, is the
most commonly used non-invasive imaging modality
around the globe. The reasons for its popularity are noninvasiveness, high sensitivity, and high prognostic value
of MPI. In ischemia cascade, perfusion abnormalities
appear within few seconds after the vascular insult
followed by appearance of systolic wall motion
abnormalities within 10 to 20 seconds.10 Chest pain and
ECG abnormalities appear quite late in the ischemia
cascade.10 MPI including single photon emission
computerized tomography (SPECT-MPI) and positron
emission tomography (PET-MPI) are considered most
sensitive modalities for early diagnosis of CAD and
precise decision-making in these patients.
Gated SPECT-MPI is the most commonly performed
nuclear cardiology procedure since 1970s. Thallium-201
is the traditional radiopharmaceutical; but over the last 2
decades it has essentially been replaced by Technetium99m labeled Methoxy IsoButyl Isonitrile (Tc-99m MIBI)
and Tetrofosmin (Tc-99m Tetrofosmin), due to its high
cost and significantly higher radiation exposure. Patients
are stressed using dynamic exercise or pharmacological
stress (vasodilator or inotrope) in those who are
unable to perform physical exercise or having other
contraindications. Radiopharmaceutical is administered
intravenously at peak stress which is distributed
according to regional perfusion, gets fixed into viable
myocardium, and gives a snap shot image. In SPECTMPI, imaging is done after 30-45 minutes after
radiotracer administration; and resultant images provide
information about perfusion (at peak stress), and wall
motion at the time of imaging patient under the gamma
camera (scanner). In Pakistan, MPI with SPECT has
been in clinical use since late eighties with rapid
progress in successive years. Fortunately, the cost of
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MPI in Pakistan is significantly low and affordable for
patients. Contribution of good number of publications
from Pakistan again proves its popularity in clinical and
research domains.11

PET-MPI in assessment of CAD is also coming up
recently in addition to its major oncological role.
However, its current utilization is significantly less as
compared to the SPECT-MPI, because of limited
number of PET/CT facilities and on-site cyclotrons as
well. Major PET isotopes are short lived like Rubidium82 (half-life 76 seconds), Oxygen-15 water (half-life 20
seconds) and N-13 ammonia (half-life 10 minutes).
Recently, Fluorine-18 (half-life 110 minute) labeled
Flurpiridaz has been introduced which is under clinical
trials. Important benefits of PET radiopharmaceuticals
are significantly lower radiation exposure and completion
of MPI within 1 hour as compared to 3-4 hours required
for SPECT-MPI.12 Image resolution of PET-MPI is much
better than SPECT-MPI and perfusion and wall motion
are studied at the time of the injection under the PET
camera. In addition, PET-MPI also provides precise
quantification of coronary flow reserve (CFR) which is
very important tool to diagnose hemodynamically
significant large and small vessels CAD.12 MPI has
similar diagnostic accuracy in diabetics and non-diabetic
population. Considering invasive coronary angiography
as gold standard in diabetic seems not justified because
of higher prevalence of small vessel disease in diabetics
and significantly lower specificity of MPI. According to a
meta-analysis, including more than 8000 patients, there
was no significant difference in sensitivity, specificity and
normalcy rate for diagnosis of CAD in diabetic and
general population.13 Another study revealed no
significant difference in the diagnostic accuracy of
diabetic and non-diabetic population having coronary
artery stenosis ≥50% and ≥70%.14 However, MPI has
significantly higher prognostic value in diabetic
population. Diabetics with abnormal MPIs tend to have
higher fatal and non-fatal cardiac events than nondiabetic population. According to a published study
including 4,755 patients who had stress MPI and
followed for 2.5 years, significantly higher non-fatal MIs
and cardiac deaths were seen in diabetic population
despite higher incidence of revascularization as well.15 It
is an established fact that negative predictive value of
normal MPI is >99%; but according to the large body of
data, event rates are significantly higher in diabetic
population despite a normal MPI.15 According to
Hakeem et al., chronic kidney disease was found to be
a confounding factor for cardiac events in diabetics.16
Based on these clinical facts, it is recommended that
warranty period of normal MPI in diabetics should be
considered up to two years rather than 2-6 years as
assumed for non-diabetic population.17 According to
ACCF/AHA guidelines published in 2010, for low to
intermediate risk diabetics, coronary artery calcium
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(CAC) scoring (Class IIa, B) and for high-risk diabetics,
MPI (Class IIb, C) is recommended. A landmark study,
Diagnosis of Ischemia in Asymptomatic Diabetes (DIAD)
study was conducted on asymptomatic American and
Canadian population using adenosine MPI. This study
revealed that 22% of asymptomatic diabetics had
abnormal MPIs; and on 5 years follow-up, no significant
difference in even rates was observed between diabetic
and non-diabetics.18 Another important finding of DIAD
study was that majority of the abnormal MPIs got
normalized in response to medical management on 3
years follow-up.18 These findings were in accordance with
the previously published COURAGE and BARI-2D trials.
IAEA sponsored a study Ischemia Assessment with
Exercise imaging in Asymptomatic Diabetics (IAEADiabetes Trial) conducted on Asian, African and Latin
American population using exercise MPI.19 This study
revealed higher prevalence of abnormal MPIs in
asymptomatic diabetics predominantly in men for
unknown reason. This study also concluded that MPI
findings were more sensitive than ECG changes in the
studied cohorts.19 Diabetes affects both diastolic and
systolic left ventricular functions and it is the diastolic
function which appears earlier due to the impaired
relaxation of the myocardium. Systolic dysfunction
appears later and its severity is correlated with duration
and magnitude of hyperglycemia. It is also observed that
diabetics with normal perfusion on gated MPI had 4.5fold increased risk of lower ejection fraction (LVEF
<45%) which was more pronounced in men than
diabetics women.20 According to Fadi et al., diabetics
had 2.7% rise in mortality for 1% decline in LVEF on
gated MPI and chronic kidney disease (CKD) was found
to be a strong predictor of lower survival in diabetics.15
Cardiac autonomic neuropathy (CAN) is common in
diabetics and considered as an independent predictor of
sudden cardiac death associated with arrhythmias. CAN
is imaged by using Iodine-123 Meta Iodo Benzyl
Guanethidine (123I-MIBG) SPECT imaging, which
shows reduced MIBG uptake and higher washout from
myocardium in CAN. In normal individuals, the heart to
mediastinum ratio (H/M ratio) of MIBG is around 2.2; but
in CAN, it declines progressively depending upon
severity of neuropathy. According to ADMIRE-HF trial,
patients with H/M ratio ≥1.6 were considered low risk
and those with H/M ratio <1.6 had high risk for cardiac
failure.21 Carbon-11 Hydroxy-Ephedrine (11C-HE) PET
imaging can also be used for the diagnosis of CAN.
Blunted heart rate response during dipyridamole stress
or recovery phase of dynamic exercise in stress SPECTMPI are also considered as predictors of CAN
associated higher mortality.21
Diabetes is a global epidemic which is considered
equivalent to CAD. CAD in diabetics is more advanced,
perplexed with poor outcome than non-diabetics.
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Screening of asymptomatic diabetics for CAD is not
recommended; but for symptomatic diabetics, MPI is a
very valid diagnostic tool. Diabetic men tend to have
higher prevalence of LV dysfunction despite normal
myocardial perfusion, and diabetic women tend to have
poorer outcome after hospitalization for ACS. Cardiac
autonomic neuropathy in diabetic is common and early
diagnosis is important to minimize sudden cardiac death
caused by arrhythmia.
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